tiprankstipranks
Trending News
More News >
Intuitive Surgical (ISRG)
NASDAQ:ISRG
US Market
Advertisement

Intuitive Surgical (ISRG) Stock Forecast & Price Target

Compare
8,558 Followers
See the Price Targets and Ratings of:

ISRG Analyst Ratings

Strong Buy
20Ratings
Strong Buy
16 Buy
3 Hold
1 Sell
Based on 20 analysts giving stock ratings to
Intuitive
Surgical
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ISRG Stock 12 Month Forecast

Average Price Target

$611.68
▲(14.49% Upside)
Based on 20 Wall Street analysts offering 12 month price targets for Intuitive Surgical in the last 3 months. The average price target is $611.68 with a high forecast of $685.00 and a low forecast of $440.00. The average price target represents a 14.49% change from the last price of $534.28.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"437":"$437","686":"$686","499.25":"$499.3","561.5":"$561.5","623.75":"$623.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":685,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$685.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":611.68,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$611.68</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":440,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$440.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[437,499.25,561.5,623.75,686],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2025","6":"Apr<br/>2025","9":"Jul<br/>2025","12":"Oct<br/>2025","25":"Oct<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,438.04,457.0369230769231,476.0338461538462,495.03076923076924,514.0276923076923,533.0246153846153,552.0215384615385,571.0184615384616,590.0153846153846,609.0123076923077,628.0092307692307,647.0061538461539,666.003076923077,{"y":685,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,438.04,451.3969230769231,464.75384615384615,478.1107692307692,491.4676923076923,504.82461538461536,518.1815384615385,531.5384615384615,544.8953846153846,558.2523076923077,571.6092307692307,584.9661538461538,598.3230769230769,{"y":611.68,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,438.04,438.19076923076926,438.3415384615385,438.4923076923077,438.64307692307693,438.7938461538462,438.9446153846154,439.0953846153846,439.24615384615385,439.3969230769231,439.54769230769233,439.6984615384615,439.84923076923076,{"y":440,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":484.76,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":506.34,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":542.85,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 39,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":521.96,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 54,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":571.88,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 49,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":573.15,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 49,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":496.36,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":517.18,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 40,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":553.29,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":537.99,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 40,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":483.12,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 39,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":469.07,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":438.04,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$685.00Average Price Target$611.68Lowest Price Target$440.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
UBS
$585$600
Hold
12.30%
Upside
Reiterated
10/23/25
UBS Reaffirms Their Hold Rating on Intuitive Surgical (ISRG)
Truist Financial Analyst forecast on ISRG
Truist Financial
Truist Financial
$525$620
Buy
16.04%
Upside
Reiterated
10/22/25
Truist Financial Sticks to Their Buy Rating for Intuitive Surgical (ISRG)
Piper Sandler Analyst forecast on ISRG
Piper Sandler
Piper Sandler
$595$610
Buy
14.17%
Upside
Reiterated
10/22/25
Piper Sandler Sticks to Its Buy Rating for Intuitive Surgical (ISRG)
Raymond James Analyst forecast on ISRG
Raymond James
Raymond James
$592$603
Buy
12.86%
Upside
Reiterated
10/22/25
Intuitive Surgical price target raised to $603 from $592 at Raymond JamesIntuitive Surgical price target raised to $603 from $592 at Raymond James
Barclays Analyst forecast on ISRG
Barclays
Barclays
$635
Buy
18.85%
Upside
Reiterated
10/22/25
Intuitive Surgical (ISRG) Gets a Buy from Barclays
Leerink Partners Analyst forecast on ISRG
Leerink Partners
Leerink Partners
$593$600
Buy
12.30%
Upside
Reiterated
10/22/25
Leerink Partners Remains a Buy on Intuitive Surgical (ISRG)
Mizuho Securities Analyst forecast on ISRG
Mizuho Securities
Mizuho Securities
$520$575
Hold
7.62%
Upside
Reiterated
10/22/25
Intuitive Surgical: Balancing Growth Potential with Market Challenges - Hold Rating Maintained
Wells Fargo Analyst forecast on ISRG
Wells Fargo
Wells Fargo
$599$600
Buy
12.30%
Upside
Reiterated
10/22/25
Wells Fargo Keeps Their Buy Rating on Intuitive Surgical (ISRG)
Robert W. Baird Analyst forecast on ISRG
Robert W. Baird
Robert W. Baird
$536$655
Buy
22.59%
Upside
Reiterated
10/22/25
Intuitive Surgical price target raised to $655 from $536 at BairdIntuitive Surgical price target raised to $655 from $536 at Baird
Stifel Nicolaus Analyst forecast on ISRG
Stifel Nicolaus
Stifel Nicolaus
$670
Buy
25.40%
Upside
Reiterated
10/22/25
Stifel Nicolaus Sticks to Its Buy Rating for Intuitive Surgical (ISRG)
Evercore ISI Analyst forecast on ISRG
Evercore ISI
Evercore ISI
$450$540
Hold
1.07%
Upside
Reiterated
10/22/25
Intuitive Surgical (ISRG) Gets a Hold from Evercore ISI
Morgan Stanley Analyst forecast on ISRG
Morgan Stanley
Morgan Stanley
$650
Buy
21.66%
Upside
Reiterated
10/22/25
Intuitive Surgical's Strong Q3 Performance and Future Growth Potential Justifies Buy RatingWe were given confidence in Cardiac expansion, as well some alternative sites of care (e.g. ASCs), and overall we continue to see the company in excellent shape. It's not surprising to see shares up c. +16% after-hours given the exceptional beat (EPS is growing c. +30% YoY currently), with incremental catalysts still to play for in 2026 and beyond (potential new platform, cardiac, endoluminal, etc.), so we remain $650 price target.
William Blair Analyst forecast on ISRG
William Blair
William Blair
Buy
Reiterated
10/22/25
Intuitive Surgical's Strong Q3 Performance and Strategic Growth Initiatives Justify Buy Rating
BTIG
$529$589
Buy
10.24%
Upside
Reiterated
10/22/25
Intuitive Surgical price target raised to $589 from $529 at BTIGIntuitive Surgical price target raised to $589 from $529 at BTIG
Citi
$650
Buy
21.66%
Upside
Reiterated
10/21/25
Intuitive Surgical's Strong Financial Performance and Strategic Advancements Drive Buy Rating
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
UBS
$585$600
Hold
12.30%
Upside
Reiterated
10/23/25
UBS Reaffirms Their Hold Rating on Intuitive Surgical (ISRG)
Truist Financial Analyst forecast on ISRG
Truist Financial
Truist Financial
$525$620
Buy
16.04%
Upside
Reiterated
10/22/25
Truist Financial Sticks to Their Buy Rating for Intuitive Surgical (ISRG)
Piper Sandler Analyst forecast on ISRG
Piper Sandler
Piper Sandler
$595$610
Buy
14.17%
Upside
Reiterated
10/22/25
Piper Sandler Sticks to Its Buy Rating for Intuitive Surgical (ISRG)
Raymond James Analyst forecast on ISRG
Raymond James
Raymond James
$592$603
Buy
12.86%
Upside
Reiterated
10/22/25
Intuitive Surgical price target raised to $603 from $592 at Raymond JamesIntuitive Surgical price target raised to $603 from $592 at Raymond James
Barclays Analyst forecast on ISRG
Barclays
Barclays
$635
Buy
18.85%
Upside
Reiterated
10/22/25
Intuitive Surgical (ISRG) Gets a Buy from Barclays
Leerink Partners Analyst forecast on ISRG
Leerink Partners
Leerink Partners
$593$600
Buy
12.30%
Upside
Reiterated
10/22/25
Leerink Partners Remains a Buy on Intuitive Surgical (ISRG)
Mizuho Securities Analyst forecast on ISRG
Mizuho Securities
Mizuho Securities
$520$575
Hold
7.62%
Upside
Reiterated
10/22/25
Intuitive Surgical: Balancing Growth Potential with Market Challenges - Hold Rating Maintained
Wells Fargo Analyst forecast on ISRG
Wells Fargo
Wells Fargo
$599$600
Buy
12.30%
Upside
Reiterated
10/22/25
Wells Fargo Keeps Their Buy Rating on Intuitive Surgical (ISRG)
Robert W. Baird Analyst forecast on ISRG
Robert W. Baird
Robert W. Baird
$536$655
Buy
22.59%
Upside
Reiterated
10/22/25
Intuitive Surgical price target raised to $655 from $536 at BairdIntuitive Surgical price target raised to $655 from $536 at Baird
Stifel Nicolaus Analyst forecast on ISRG
Stifel Nicolaus
Stifel Nicolaus
$670
Buy
25.40%
Upside
Reiterated
10/22/25
Stifel Nicolaus Sticks to Its Buy Rating for Intuitive Surgical (ISRG)
Evercore ISI Analyst forecast on ISRG
Evercore ISI
Evercore ISI
$450$540
Hold
1.07%
Upside
Reiterated
10/22/25
Intuitive Surgical (ISRG) Gets a Hold from Evercore ISI
Morgan Stanley Analyst forecast on ISRG
Morgan Stanley
Morgan Stanley
$650
Buy
21.66%
Upside
Reiterated
10/22/25
Intuitive Surgical's Strong Q3 Performance and Future Growth Potential Justifies Buy RatingWe were given confidence in Cardiac expansion, as well some alternative sites of care (e.g. ASCs), and overall we continue to see the company in excellent shape. It's not surprising to see shares up c. +16% after-hours given the exceptional beat (EPS is growing c. +30% YoY currently), with incremental catalysts still to play for in 2026 and beyond (potential new platform, cardiac, endoluminal, etc.), so we remain $650 price target.
William Blair Analyst forecast on ISRG
William Blair
William Blair
Buy
Reiterated
10/22/25
Intuitive Surgical's Strong Q3 Performance and Strategic Growth Initiatives Justify Buy Rating
BTIG
$529$589
Buy
10.24%
Upside
Reiterated
10/22/25
Intuitive Surgical price target raised to $589 from $529 at BTIGIntuitive Surgical price target raised to $589 from $529 at BTIG
Citi
$650
Buy
21.66%
Upside
Reiterated
10/21/25
Intuitive Surgical's Strong Financial Performance and Strategic Advancements Drive Buy Rating
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Intuitive Surgical

1 Month
xxx
Success Rate
16/24 ratings generated profit
67%
Average Return
+3.15%
reiterated a xxx
rating 24 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of +3.15% per trade.
3 Months
xxx
Success Rate
23/31 ratings generated profit
74%
Average Return
+7.72%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 74.19% of your transactions generating a profit, with an average return of +7.72% per trade.
1 Year
Richard NewitterTruist Financial
Success Rate
26/34 ratings generated profit
76%
Average Return
+25.03%
reiterated a buy rating 11 days ago
Copying Richard Newitter's trades and holding each position for 1 Year would result in 76.47% of your transactions generating a profit, with an average return of +25.03% per trade.
2 Years
xxx
Success Rate
27/34 ratings generated profit
79%
Average Return
+55.01%
reiterated a xxx
rating 11 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 79.41% of your transactions generating a profit, with an average return of +55.01% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ISRG Analyst Recommendation Trends

Rating
Jun 25
Jul 25
Aug 25
Sep 25
Oct 25
Strong Buy
0
0
0
2
2
Buy
37
40
39
35
14
Hold
3
6
5
5
1
Sell
1
1
2
1
1
Strong Sell
0
0
0
0
0
total
41
47
46
43
18
In the current month, ISRG has received 16 Buy Ratings, 1 Hold Ratings, and 1 Sell Ratings. ISRG average Analyst price target in the past 3 months is 611.68.
Each month's total comprises the sum of three months' worth of ratings.

ISRG Financial Forecast

ISRG Earnings Forecast

Next quarter’s earnings estimate for ISRG is $2.25 with a range of $2.13 to $2.44. The previous quarter’s EPS was $2.40. ISRG beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year ISRG has Preformed in-line its overall industry.
Next quarter’s earnings estimate for ISRG is $2.25 with a range of $2.13 to $2.44. The previous quarter’s EPS was $2.40. ISRG beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year ISRG has Preformed in-line its overall industry.

ISRG Sales Forecast

Next quarter’s sales forecast for ISRG is $2.72B with a range of $2.67B to $2.82B. The previous quarter’s sales results were $2.51B. ISRG beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year ISRG has Preformed in-line its overall industry.
Next quarter’s sales forecast for ISRG is $2.72B with a range of $2.67B to $2.82B. The previous quarter’s sales results were $2.51B. ISRG beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year ISRG has Preformed in-line its overall industry.

ISRG Stock Forecast FAQ

What is ISRG’s average 12-month price target, according to analysts?
Based on analyst ratings, Intuitive Surgical’s 12-month average price target is 611.68.
    What is ISRG’s upside potential, based on the analysts’ average price target?
    Intuitive Surgical has 14.49% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is ISRG a Buy, Sell or Hold?
          Intuitive Surgical has a consensus rating of Strong Buy which is based on 16 buy ratings, 3 hold ratings and 1 sell ratings.
            What is Intuitive Surgical’s price target?
            The average price target for Intuitive Surgical is 611.68. This is based on 20 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $685.00 ,the lowest forecast is $440.00. The average price target represents 14.49% Increase from the current price of $534.28.
              What do analysts say about Intuitive Surgical?
              Intuitive Surgical’s analyst rating consensus is a Strong Buy. This is based on the ratings of 20 Wall Streets Analysts.
                How can I buy shares of ISRG?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis